Do we find relevant parameters for in vitro cytotoxicity testing?

C A Reinhardt1

  • 1Cell Lab, Behavioral Biology, Federal Institute of Technology, ETH-Center, Zurich, Switzerland.

Molecular Toxicology
|January 1, 1987
PubMed

Insights

Developing effective in vitro cytotoxicity tests requires an integrated approach, combining cell-based assays and structure-activity analyses to meet public demand for alternatives to animal testing.

Area of Science:

  • Toxicology
  • In vitro toxicology
  • Alternative testing methods

Background:

  • Current cytotoxicity test strategies are reviewed against the need for reliable in vitro alternatives to animal testing.
  • Public expectations for non-animal testing methods are high.
  • Existing in vitro and short-term mutagenicity tests highlight the limitations of a single 'supertest' approach.

Purpose of the Study:

  • To review the current strategy for designing cytotoxicity tests.
  • To discuss the relevance of various in vitro tests for topical and neurotoxicity assessment.
  • To propose an integrated approach for safety testing that aligns with public expectations and scientific rigor.

Main Methods:

  • Review of current cytotoxicity testing strategies.
  • Discussion of specific in vitro tests for topical and neurotoxicity.
  • Analysis of past experiences with in vitro mutagenicity testing.
  • Proposal for an integrated safety testing framework.

Main Results:

  • A single 'supertest' is insufficient for comprehensive safety assessment.
  • Various cytotoxicity tests have limitations when assessed in isolation.
  • An integrated approach is necessary to fulfill the goals of alternative testing.

Conclusions:

  • Effective in vitro safety testing necessitates a combined strategy.
  • Integrating results from cell-based assays, structure-activity analyses, and kinetic/metabolic studies is crucial.
  • The relevance of integrated approaches should be evaluated based on the organisms potentially exposed.